CGON (CG Oncology) FFO


CGON CG Oncology Inc CGON
12 GF Score
Price $71.96
! 6 Warning Signs
View Full Analysis

What is CG Oncology FFO?

FFO (Funds from operations) only applies to REITs.

CGON
12GF Score
CG Oncology Inc CGON
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CG Oncology Business Description

Address 400 Spectrum Center Drive, Suite 2040, Irvine, CA, USA, 92618
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer. The company's candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
12GF Score

Get the complete analysis for CGON

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$71.96
Price